EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

USP25 Promotes Glycolysis of Acute Myeloid Leukemia Cells and Enhances Tumor Immunity

Nianxue Wang, Can Yang, Ruya Zhang, Wei Ren, Biao Shen

Archivum Immunologiae et Therapiae Experimentalis · 2026

DOI: 10.2478/aite-2026-0020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, 2026. Verfasst von Nianxue Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Basic Medical School, Guizhou Medical University, Guiyang, Guizhou 561113, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is an incursionary hematopoietic tumor with frequent relapses and an unfavorable prognosis. Ubiquitin-specific peptidase 25 (USP25) mediates the progression of various cancers, but its role in AML remains uncharted. The expression of USP25 in AML was analyzed in silico , in vitro, and in vivo through real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot. The function of USP25 in proliferation, apoptosis, glycolysis, and immunity in AML was addressed through cell counting kit-8 (CCK-8), flow cytometry, detection of glucose consumption, lactate production, extracellular acidification rate (ECAR), and oxygen consumption rate (OCR), immunohistochemistry, immunofluorescence, and Western blot. The mechanism of USP25 in AML was explored via co-immunoprecipitation (Co-IP), ubiquitination, cycloheximide, and Western blot. Upregulation of USP25 indicated a poor overall survival in AML patients. Knock-in and knock-down results revealed that USP25 enhanced viability, the level of glucose consumption, lactate production, ECAR, and the level of anti-glucose transporter type 1 (GLUT1) and hexokinase-2 (HK2), but reduced the apoptosis rate and the OCR level. Mechanically, USP25 directly bound and deubiquitinated c-Myc. An upregulation of c-Myc and programmed cell death ligand 1 (PD-L1) was found in AML. Knockdown of c-Myc decreased USP25-induced cell viability, glucose consumption, and lactate production level. In vivo , knockdown of USP25 decreased tumor volume and weight, the ki-67 expression, and the levels of c-Myc and PD-L1, but elevated the levels of cluster of differentiation 4 (CD4) and cluster of differentiation 8 (CD8). USP25 facilitated proliferation, glycolysis, and immunity through deubiquitinating c-Myc in AML. The results identified USP25 as a possible target for AML treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteUbiquitin ThiolesteraseHumansGlycolysisAnimalsApoptosisMiceCell Line, TumorCell ProliferationFemaleUbiquitinationB7-H1 AntigenMaleProto-Oncogene Proteins c-mycPrognosis

Stichwörter der Autor:innen

Acute myeloid leukemiaGlycolysisImmunityPD-L1USP25Ubiquitination

Substanzen

Ubiquitin ThiolesteraseB7-H1 AntigenProto-Oncogene Proteins c-mycCD274 protein, human

Autor:innen und Institutionen

  • Department of Immunology, Basic Medical School, Guizhou Medical University, Guiyang, Guizhou 561113, China.
  • Department of Pediatric Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
  • Department of Hematopoietic Stem Cell Transplantation, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology a…

Zitieren

APA

Wang, N., Yang, C., Zhang, R., Ren, W., & Shen, B. (2026). USP25 Promotes Glycolysis of Acute Myeloid Leukemia Cells and Enhances Tumor Immunity. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.2478/aite-2026-0020

Vancouver

Wang N, Yang C, Zhang R, Ren W, Shen B. USP25 Promotes Glycolysis of Acute Myeloid Leukemia Cells and Enhances Tumor Immunity. Archivum Immunologiae et Therapiae Experimentalis. 2026. doi:10.2478/aite-2026-0020

BibTeX
@article{Wang2026,
  author = {Wang, Nianxue and Yang, Can and Zhang, Ruya and Ren, Wei and Shen, Biao},
  title = {USP25 Promotes Glycolysis of Acute Myeloid Leukemia Cells and Enhances Tumor Immunity},
  journal = {Archivum Immunologiae et Therapiae Experimentalis},
  year = {2026},
  doi = {10.2478/aite-2026-0020}
}
Kostenlos starten →